Last reviewed · How we verify
NCT07016984
Comfort Level in Premature Infants Undergoing Retinopathy of Prematurity Screening
NA trial testing standard phototherapy eye patches in Premature in 90 participants. Completed in 10 March 2025.
28 February 2025
Quick facts
| Lead sponsor | Istanbul Nisantasi University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 1 January 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 10 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- standard phototherapy eye patches
Conditions studied
- Premature — all drugs for Premature →
- Retinopathy of Prematurity — all drugs for Retinopathy of Prematurity →
- Pain — all drugs for Pain →
Sponsor
Istanbul Nisantasi University
Who can join
21 Days and older, any sex, with Premature or Retinopathy of Prematurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retinopathy of prematurity (ROP) screening is a routine yet painful procedure for premature infants, often necessitating pharmacological mydriasis. The associated light exposure due to dilated pupils can increase stress and reduce infant comfort. This study aimed to investigate the effect of using a phototherapy eye mask during mydriasis on the comfort levels of premature infants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07016984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature
Currently open trials in the same condition.
- NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
- NCT07049900 — Baby ABS (Abdominal Binder Study) · NA · recruiting
- NCT07154186 — Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients · recruiting
- NCT07088302 — Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates · NA · recruiting
- NCT06812507 — Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their He · NA · recruiting
Other Istanbul Nisantasi University trials
Trials by the same sponsor.
- NCT07428070 — Contextually Enriched Individualized Exercise Versus Contextually Fixed Exercise for Rotator Cuff-Related Shoulder Pain · NA · not yet recruiting
- NCT07016204 — CBT Effects on Neurophysiological and Psychological Outcomes in Body Dysmorphic Disorder · NA · completed
- NCT07037017 — CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa · NA · recruiting
- NCT06844058 — Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression · NA · recruiting
- NCT06758362 — EMDR vs. CBT for PTSD · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07016984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Nisantasi University
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing